The demand for endoluminal suturing device in USA is projected to grow from USD 32.4 million in 2025 to USD 55.0 million by 2035, at a CAGR of 5.4%. Needle-based Suturing Devices will dominate with a 47.0% market share, while bariatric will lead the application segment with a 53.0% share.